Celecoxib enhances the detoxification of diethylnitrosamine in rat liver cancer
about
Plasma Lipid Profiling in a Rat Model of Hepatocellular Carcinoma: Potential Modulation Through Quinolone Administration.Cholestatic hepatitis with small duct injury associated with celecoxib.Cancer prevention mediated by caffeic acid phenethyl ester involves cyp2b1/2 modulation in hepatocarcinogenesis.
P2860
Celecoxib enhances the detoxification of diethylnitrosamine in rat liver cancer
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Celecoxib enhances the detoxification of diethylnitrosamine in rat liver cancer
@en
Celecoxib enhances the detoxification of diethylnitrosamine in rat liver cancer.
@nl
type
label
Celecoxib enhances the detoxification of diethylnitrosamine in rat liver cancer
@en
Celecoxib enhances the detoxification of diethylnitrosamine in rat liver cancer.
@nl
prefLabel
Celecoxib enhances the detoxification of diethylnitrosamine in rat liver cancer
@en
Celecoxib enhances the detoxification of diethylnitrosamine in rat liver cancer.
@nl
P2093
P2860
P356
P1476
Celecoxib enhances the detoxification of diethylnitrosamine in rat liver cancer
@en
P2093
Adolfo Sierra-Santoyo
José Roberto Macías-Pérez
Martha Estela Salcido-Neyoy
Olga Beltrán-Ramírez
Saúl Villa-Treviño
P2860
P304
P356
10.3748/WJG.15.2345
P407
P577
2009-05-01T00:00:00Z